lung disease

Dr. Lynn D’Andrea knew something was amiss when three teenagers with similar mysterious, dangerous lung injuries came into the Children’s Hospital of Wisconsin one after another, gasping for air. As the only pulmonologist on duty that Fourth of July holiday week, D’Andrea noticed those alarming cases followed on the heels of another teen who had… Read more

Messenger RNA, which can induce cells to produce therapeutic proteins, holds great promise for treating a variety of diseases. The biggest obstacle to this approach so far has been finding safe and efficient ways to deliver mRNA molecules to the target cells. In an advance that could lead to new treatments for lung disease, MIT… Read more

Tuberculosis, caused by Mycobacterium tuberculosis, was in 2016 the most common causative pathogen for death by infectious diseases. Investigating the biology of infection and disease development is important in the quest to end tuberculosis. In a new study, researchers conducted an integrative analysis of human and pathogen genome variations in tuberculosis. Genome-wide association study (GWAS)… Read more

Promising research towards a possible stem cell treatment for several lung conditions has been developed by scientists from the UNC School of Medicine and North Carolina State University. The conditions include idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis — often-fatal conditions that affect tens of millions of Americans. The team… Read more

Although people diagnosed with cystic fibrosis are surviving longer than ever before, their lifespan is nearly 10 years longer in Canada than the United States, reports new research. Cystic fibrosis is a genetic disease that affects the lungs, pancreas, liver, intestines, sinuses, and sex organs. Cystic fibrosis causes your mucus to be thick and sticky… Read more